These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16019174)

  • 21. High-Frequency Distortion-Product Otoacoustic Emission Repeatability in a Patient Population.
    Dreisbach L; Zettner E; Chang Liu M; Meuel Fernhoff C; MacPhee I; Boothroyd A
    Ear Hear; 2018; 39(1):85-100. PubMed ID: 28678077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency responses of two- and three-tone distortion product otoacoustic emissions in Mongolian gerbils.
    Mills DM
    J Acoust Soc Am; 2000 May; 107(5 Pt 1):2586-602. PubMed ID: 10830382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression and enhancement of distortion-product otoacoustic emissions by interference tones above f(2). I. Basic findings in rabbits.
    Martin GK; Stagner BB; Jassir D; Telischi FF; Lonsbury-Martin BL
    Hear Res; 1999 Oct; 136(1-2):105-23. PubMed ID: 10511630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of negative middle ear pressure on distortion product otoacoustic emissions and application of a compensation procedure in humans.
    Sun XM; Shaver MD
    Ear Hear; 2009 Apr; 30(2):191-202. PubMed ID: 19194291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of relative probe-tone levels on distortion product otoacoustic emissions.
    Rasmussen AN; Popelka GR; Osterhammel PA; Nielsen LH
    Scand Audiol; 1993; 22(4):223-9. PubMed ID: 8146586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression and enhancement of distortion-product otoacoustic emissions by interference tones above f(2). II. Findings in humans.
    Martin GK; Villasuso EI; Stagner BB; Lonsbury-Martin BL
    Hear Res; 2003 Mar; 177(1-2):111-22. PubMed ID: 12618323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of Minor Conductive Hearing Loss in Humans Using Distortion Product Otoacoustic Emissions.
    Marcrum SC; Kummer P; Steffens T
    Ear Hear; 2017; 38(4):391-398. PubMed ID: 28169838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M; Mom T; Guitton M; Poncet JL; Bonfils P; Avan P
    Audiology; 2001; 40(3):113-22. PubMed ID: 11465293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distortion product otoacoustic emission level maps from normal and noise-damaged cochleae.
    Meinke DK; Clavier OH; Norris J; Kline-Schoder R; Allen L; Buckey JC
    Noise Health; 2013; 15(66):315-25. PubMed ID: 23955128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of distortion product emission amplitude on primary-tone stimulus levels during middle-ear pressure changes.
    Richter B; Hauser R; Löhle E
    Acta Otolaryngol; 1994 May; 114(3):278-84. PubMed ID: 8073861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABR and DPOAE detection of cochlear damage by gentamicin.
    Shi Y; Martin WH
    J Basic Clin Physiol Pharmacol; 1997; 8(3):141-55. PubMed ID: 9429983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
    Neely ST; Gorga MP; Dorn PA
    J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochlear Mechanisms and Otoacoustic Emission Test Performance.
    Go NA; Stamper GC; Johnson TA
    Ear Hear; 2019; 40(2):401-417. PubMed ID: 29952805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of the 2f1-f2 otoacoustic emission in humans.
    Harris FP; Probst R; Xu L
    Hear Res; 1992 Dec; 64(1):133-41. PubMed ID: 1490896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of relative levels of the primary tones on distortion product otoacoustic emissions in normal-hearing subjects.
    Beattie RC; Jones RL
    Audiology; 1998; 37(4):187-97. PubMed ID: 9723765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of distortion product otoacoustic emissions in infants with a combined air and bone conduction stimulus.
    Lalos T; Dobrev I; Probst R; Röösli C
    Int J Pediatr Otorhinolaryngol; 2023 Aug; 171():111628. PubMed ID: 37329704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.